Lessons learned from HIV-1 vaccine trials: new priorities and directions.
Journal Article (Journal Article)
A vaccine against human immunodeficiency virus (HIV) seems to be on the horizon. Correlates of risk of infection for [corrected] the RV144 vaccine trial have been found. There is understanding of what makes HIV envelope-specific antibodies broadly neutralizing and new T cell vaccine approaches can overcome virus variability.
- McMichael, AJ; Haynes, BF
- April 18, 2012
Volume / Issue
- 13 / 5
Start / End Page
- 423 - 427
Pubmed Central ID
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)
- United States